VanEck Associates
TDOC icon

VanEck Associates’s Teladoc Health TDOC Stock Holding History

VanEck Associates’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,822
Closed -$48K – 1477
2026
Q1 		$48K Sell
8,822
-328
-4% -$1.84K ﹤0.01% 1335
2025
Q4 		$64K Buy
9,150
+4,607
+101% +$36.1K ﹤0.01% 1345
2025
Q3 		$35K Buy
4,543
+959
+27% +$7.49K ﹤0.01% 1356
2025
Q2 		$31K Sell
3,584
-220
-6% -$1.59K ﹤0.01% 1341
2025
Q1 		$30K Buy
3,804
+343
+10% +$3.47K ﹤0.01% 1321
2024
Q4 		$31K Buy
3,461
+659
+24% +$6.36K ﹤0.01% 1320
2024
Q3 		$24K Sell
2,802
-1,015
-27% -$8.4K ﹤0.01% 1307
2024
Q2 		$37K Hold
3,817
– – ﹤0.01% 1304
2024
Q1 		$58K Buy
3,817
+228
+6% +$4.14K ﹤0.01% 1274
2023
Q4 		$77K Buy
3,589
+606
+20% +$11.2K ﹤0.01% 1259
2023
Q3 		$55K Hold
2,983
– – ﹤0.01% 1277
2023
Q2 		$76K Buy
2,983
+250
+9% +$6.29K ﹤0.01% 1269
2023
Q1 		$71K Sell
2,733
-152
-5% -$4.07K ﹤0.01% 1283
2022
Q4 		$68K Sell
2,885
-920
-24% -$24.8K ﹤0.01% 1294
2022
Q3 		$96K Buy
3,805
+2,226
+141% +$78.1K ﹤0.01% 1181
2022
Q2 		$52K Sell
1,579
-15,723
-91% -$668K ﹤0.01% 1284
2022
Q1 		$1.25M Buy
17,302
+2,999
+21% +$216K ﹤0.01% 794
2021
Q4 		$1.31M Buy
14,303
+11,437
+399% +$1.37M ﹤0.01% 797
2021
Q3 		$363K Sell
2,866
-7,021
-71% -$1.02M ﹤0.01% 952
2021
Q2 		$1.64M Sell
9,887
-11,353
-53% -$1.84M ﹤0.01% 705
2021
Q1 		$3.86M Buy
+21,240
New +$4.93M 0.01% 480

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

VanEck Associates's TDOC Position: Q2 2026 in Review

VanEck Associates sold out of Teladoc Health (TDOC) in Q2 2026, closing a stake of 8,822 shares — an estimated $48K sold.

VanEck Associates first reported a position in TDOC in Q1 2021 and held it in 21 quarters. The position peaked at $3.86M in Q1 2021. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • VanEck Associates reported no remaining Teladoc Health position as of Q2 2026 after selling out during the quarter.
  • VanEck Associates sold 8,822 Teladoc Health shares in Q2 2026, an estimated $48K.
  • VanEck Associates first reported a position in Teladoc Health in Q1 2021 and held it in 21 quarters.
  • VanEck Associates's Teladoc Health position peaked at $3.86M in Q1 2021.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.